Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat Female Sexual Dysfunction in the U.S.(?)

Council Members in this Study Group: 47

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Steven Drosman, MD
President
Steven Drosman, MD

Steven Drosman, MD, is in OB/GYN private practice and President of Steven Drosman, M.D. and Genesis Center for Clinical Research in San Diego, CA. Dr. Drosman performs gynecologic procedures and related surgery, and researches and lectures on topics such as hormone therapy and menopause and contraception....

David Portman, MD, Director, Columbus Center For Womens Health Research David Portman, MD
Director
Columbus Center For Womens Health Research

David Portman, MD, is Director and Principal Investigator of the Columbus Center for Women's Health Research. Dr. Portman is also a Clincial Investigator at The Ohio State University. He has conducted over 100 clinical studies in areas of contraception, osteoporosis, menopause, and sexual dysfunction...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Analysis of: J&J Hasn't Given Up on Sex Pill for Men | www.forbes.com

I think that dapoxetine does have an excellent chance for approval in Europe. The fact that the indication is not recognized by the FDA is ludicrous. It is a significant condition, and really destroys mens' self esteem, sex lives, and relationships. Hopefully, the Europeans will be more enlightened....

Analysis of: FDA approves Lilly's Evista for breast cancer | www.marketwatch.com

Evista sales may improve due to the FDA approval for both prevention of invasive breast cancer and osteoporosis but the increase is likely to be very modest.  It has advantages over tamoxifen in that Evista does not cause endometrial hyperplasia or cancer of the uterus, however it still carries...

April 27, 2007
Another misstep
Analysis of: A Revolution In Fetal Monitoring | www.medicalnewstoday.com

This is another technique that will increase cost and not change patient outcome.

March 5, 2007
Astelin

Astelin is a less well known and less widely used preparation for the treatment of seasonal rhinitis but should become more widely used due to articles like this that demonstrate its efficacy and benefits over nasal steroids.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Other Freestanding Healthcare Facility
  • Academic Institution*
  • Contract Research Organization, Independent/Small

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Physician - Director
  • Director
  • President
  • Physician - Division Head
  • Physician - Department Chair

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880